Gold Nanoparticles Market to Cross $7600 million Revenue by 2030

Gold Nanoparticles Market Overview

“The global Gold Nanoparticles Market is expected to grow rapidly at a 13.85% CAGR consequently. It will more than 7800 million dollars in gold nanoparticles are expected to be sold globally by the end of 2030.”

Gold nanoparticles, a novel nanomaterial, offer a wide range of medical and biological applications due to their multifunctional nature.

Nanotechnology has made significant progress in creating functional nanoparticles, with metal nanoparticles being widely used in medical applications. Gold nanoparticles (AuNPs) are considered extraordinary due to their unique functional characteristics and ease of production. Their intrinsic properties can be adjusted by modifying their characterisation, such as form, size, and aspect ratio, to enhance their optical, electronics, and physicochemical properties.

AuNPs are versatile medical materials used in various processes like drug and gene delivery, photothermal therapy, radiation therapy, diagnostics, X-ray imaging, and CT. However, there is no systematic study on their medical applications. This article provides an overview of synthesis, modification, and characterization techniques of AuNPs, their medical applications, and certain biological activities, serving as a reference for future research.

The application of gold nanoparticles is vast and varied.

AuNPs are widely used in bionanotechnology due to their unique characteristics and diverse surface functionalities. Their ease of functionalization makes them suitable for nanobiological assemblies containing oligonucleotides, antibodies, and proteins. AuNP bioconjugates offer potential for developing novel biomaterials for biological system study.

AuNPs' flexibility has made them useful for various biomedical applications. In diagnostics, their physicochemical features like surface plasmon resonance, conductivity, and redox behavior can be altered, allowing detectable signals. AuNPs' large surface area also makes them ideal therapeutic agent platforms, allowing for the presentation of multifunctional moieties like medicines and targeting agents.

Are gold nanoparticles harmful?

Pure gold nanoparticles pose potential health risks in vitro and vivo, but their harmful effects can be mitigated or even prevented through proper surface modifications.

Advancements in nanotechnology and increasing demand for metal nanoparticles in various industries are expected to significantly impact gold nanoparticle demand. Adoption of gold nanoparticles has surged in the medical field for nano-technology-based diagnostics and therapies, aiming for widespread use in tumor and cancer treatment and patient-focused diagnosis.

The nanoparticles sector is gaining interest in gold nanoparticles' potential applications. Studies suggest they can boost biosynthesis in plant plastids through injection into cells, allowing for evaluation of their performance. Gold nanoparticles are also being considered as osteogenic agents, impacting osteoblast differentiation simulation in dentistry. Additionally, titanium dental implant surfaces are gaining popularity, with gold nanoparticles gaining major adoption.

Gold nanoparticles are being developed and manufactured in dentinal tubules and layers for non-invasive and non-destructive structure viewing, a new trend in the global gold nanoparticles market, which is widely used in dentistry as contrast agents for OCT techniques.

>>> Download Sample Report Now: https://marketreportservice.com/request-sample/gold-nanoparticles-market-54516

Market Dynamics

Demand Outlook

The demand for gold nanoparticles is being driven by their ultra-light weight

Gold nanoparticles' ultra-light weight has led to increased use in glass and optics, offering properties similar to bulk substances in smaller spaces. The global trend towards smaller electronic gadgets has fueled demand for ultra-thin nanoparticles, with nanowires and inks being developed for electronic biosensors and storage devices. This lightweight nature allows for efficient use in various applications.

The region, the world's largest electronics manufacturing hub, is bolstered by the growth of the nanotechnology sector in countries like India, Korea, Taiwan, and China, and the expansion of photovoltaic and high-precision printing industries.

Restraints

The usage of nanoparticles is accompanied by stringent rules and safety concerns

The gold nanoparticles market faces significant restraint due to strict regulations and safety concerns related to nanomaterials. Governments and regulatory agencies enforce strict protocols to ensure responsible use in industries like healthcare. These health, environmental, and safety concerns can hinder industry expansion, affecting compliance with regulations, proper handling and disposal, and addressing public concerns about potential dangers.

Trends

The global gold nanoparticles market is experiencing a surge in the use of gold nanoparticles in targeted medication delivery systems due to their high precision and efficacy in delivering medicinal ingredients. These nanoparticles can be functionalized with precise targeting ligands, allowing for selective delivery of medications, reducing off-target effects and improving therapeutic outcomes, aligning with the growing focus on personalized medicine.

Market Segment Analysis

Healthcare will continue to be the largest end-user of gold nanoparticles.

The healthcare sector is experiencing a significant increase in nanotechnology adoption, particularly in diagnostics, medical imaging, and medicines. R&D initiatives focusing on cancer therapies and prevention are expected to boost market growth. This will increase demand for gold nanoparticles in the sector, with healthcare being the largest end-user of these nanoparticles in terms of revenue.

The global gold nanoparticles market is competitive and dominated by multinational and medium-sized firms. The cost-exhaustive business produces modest output for limited applications. Major research and development spending in application-specific gold nanoparticles is a key feature. Major players like BBI Solutions, Johnson Matthey Plc, Meliorum Technologies, Innova Biosciences, and Cytodiagnostics support the growth of this market.

Competitive Landscape of the Gold Nanoparticles Market

• Tanaka Holdings Co. Ltd. (Japan)
• The Metalor Group (Switzerland)
• Sigma Aldrich (US)
• NanoComposix (US)
• Innova Biosciences (UK)
• Creative Diagnostics (US)
• Sona Nanotech Inc. (Canada)
• Cima NanoTech (US)
• NanoTemper Technologies (Germany)
• NN-Labs LLC (US)
• Meliorum Technologies Inc. (US)
• Strem Chemicals Inc. (US)
• Cytodiagnostics Inc. (Canada)
• Goldsol Inc. (US)
• BBI Solutions (UK)
• NanoHybrids Inc. (US)
• Nanopartz Inc. (US)
• Nanosphere Inc. (US)
• Nanostellar Inc. (US)
• Solaris Nanosciences Corporation (US)

Recent Developments in Gold Nanoparticles Market

In October 2022, Nanostellar Inc. announced a breakthrough in the production of gold nanoparticles with high crystalline purity, enabling advanced applications in electronics and catalysis.

In August 2022, Tanaka Holdings Co. Ltd. launched a new generation of gold nanoparticles with controlled size and shape, offering enhanced catalytic properties for use in green chemistry applications.

In May 2022, BBI Solutions introduced a range of gold nanoparticle-based lateral flow assays, enabling quick and reliable point-of-care testing for various medical conditions.

In February 2022, Nanosphere Inc. unveiled a cutting-edge diagnostic platform utilizing gold nanoparticles for rapid and accurate detection of infectious diseases.

In November 2021, Goldsol Inc. announced the development of a breakthrough gold nanoparticle-based cancer treatment, demonstrating promising results in preclinical trials.

In September 2021, Nanopartz Inc. launched a novel series of gold nanorods with improved optical properties, offering enhanced performance in imaging and sensing applications.

Regional Insights

North America dominates the gold nanoparticles market due to its superior healthcare infrastructure, significant research and development investments, and high technological innovation acceptance. The region's numerous major players contribute to its dominance. The growing demand for gold nanoparticles in medical diagnostics, cancer imaging, and drug delivery systems, along with rising disposable income and increased awareness of modern medical treatments, further strengthens North America's market dominance.

Europe is experiencing rapid growth in the gold nanoparticles industry due to its established healthcare system, strong research and development focus, significant players in the nanotechnology industry, collaborations between academic institutions and industry, and favorable government initiatives. The region's emphasis on sustainability and environmentally friendly solutions also contributes to the growing use of gold nanoparticles in various medical applications, including catalysis.

Segments Covered in the Gold Nanoparticles Market

Gold Nanoparticles Market by Application

• Imaging
• Targeted Drug Delivery
• Proton Therapy
• In-Vitro Assays

Gold Nanoparticles Market by End-User

• Healthcare
• Electronics
• Chemicals
• Others

Gold Nanoparticles Market by Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

Frequently Asked Questions:

1. Which region has the largest share in Global Gold Nanoparticles Market?

North America region held the highest share in 2022.

2. What is the growth rate of Global Gold Nanoparticles Market?

The Global Gold Nanoparticles Market is growing at a CAGR of 13.85% during forecasting period 2023-2029.

3. What is scope of the Global Gold Nanoparticles Market report?

Global Gold Nanoparticles Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Gold Nanoparticles Market?

The important key players in the Global Gold Nanoparticles Market are – BBI Solutions, Agilent Technologies, Cline Scientific, Danaher Corporation, Cytodiagnostics, Goldsol, Meliorum Technologies, Hitachi Ltd, Nano Composix, Tanaka Technologies, Sigma-Aldrich, Wyatt Technology Corporation., American Elements, Nanopartz, and NanoHybrids.